$146.88
-2.32-1.55%
At Close: -
$146.88
00.00%
After Hours: 6:01 PM EDT
15 minutes delayed
want to know what
the Bulls & Bears Say?
Hess (NYSE:HES) 주식, 분석가 평가, 목표 가격, 예측
Hess Corp의 합의된 목표 주가는 97개의 최신 애널리스트 평가를 살펴보고 설정되었습니다. 마지막 3개의 애널리스트 평가는 6월 5, 2024, 5월 16, 2024 및 5월 13, 2024에 Citigroup, Susquehanna 및 Mizuho에서 발표되었습니다. Citigroup, Susquehanna 및 Mizuho 사이의 평균 목표 주가는 $179로, 이러한 3개의 애널리스트 평가에서 Hess Corp에 대한 암시된 21.87% upside가 있습니다.
추천을 하는 애널리스트 회사들1
Citigroup
Susquehanna
Mizuho
Piper Sandler
UBS
1애널리스트 평가로부터 계산됨
Hess에 대한 애널리스트 평점
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/05/2024 | Buy Now | 8.93% | Citigroup | Scott Gruber | $145 → $160 | Maintains | Neutral | Get Alert |
| 05/16/2024 | Buy Now | 13.7% | Susquehanna | Biju Perincheril | $164 → $167 | Maintains | Neutral | Get Alert |
| 05/13/2024 | Buy Now | 42.97% | Mizuho | Nitin Kumar | $205 → $210 | Maintains | Neutral | Get Alert |
| 04/22/2024 | Buy Now | 11.66% | Susquehanna | Biju Perincheril | $156 → $164 | Maintains | Neutral | Get Alert |
| 04/18/2024 | Buy Now | 17.78% | Piper Sandler | Ryan Todd | $172 → $173 | Maintains | Overweight | Get Alert |
| 03/20/2024 | Buy Now | 39.57% | Mizuho | Nitin Kumar | $200 → $205 | Maintains | Neutral | Get Alert |
| 03/14/2024 | Buy Now | 17.1% | Piper Sandler | Ryan Todd | $169 → $172 | Maintains | Overweight | Get Alert |
| 03/04/2024 | Buy Now | 6.21% | Susquehanna | Biju Perincheril | $152 → $156 | Maintains | Neutral | Get Alert |
| 02/26/2024 | Buy Now | 36.17% | Mizuho | Nitin Kumar | $170 → $200 | Maintains | Neutral | Get Alert |
| 01/26/2024 | Buy Now | 3.49% | Susquehanna | Biju Perincheril | $160 → $152 | Maintains | Neutral | Get Alert |
| 12/14/2023 | Buy Now | 32.76% | UBS | Josh Silverstein | $210 → $195 | Maintains | Buy | Get Alert |
| 11/07/2023 | Buy Now | 16.42% | Argus Research | Bill Selesky | → $171 | Upgrade | Hold → Buy | Get Alert |
| 11/02/2023 | Buy Now | 13.02% | Bernstein | Bob Brackett | $189 → $166 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/26/2023 | Buy Now | 8.93% | Susquehanna | Biju Perincheril | $197 → $160 | Downgrade | Positive → Neutral | Get Alert |
| 10/24/2023 | Buy Now | 16.42% | Wells Fargo | Roger Read | $170 → $171 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/24/2023 | Buy Now | — | Raymond James | John Freeman | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/18/2023 | Buy Now | 10.97% | Citigroup | Scott Gruber | $155 → $163 | Maintains | Neutral | Get Alert |
| 10/18/2023 | Buy Now | 34.12% | Susquehanna | Biju Perincheril | $187 → $197 | Maintains | Positive | Get Alert |
| 10/18/2023 | Buy Now | 31.4% | Raymond James | John Freeman | $166 → $193 | Maintains | Outperform | Get Alert |
| 10/17/2023 | Buy Now | 12.34% | Morgan Stanley | Devin McDermott | $166 → $165 | Maintains | Overweight | Get Alert |
| 10/09/2023 | Buy Now | 15.06% | Piper Sandler | Ryan Todd | $167 → $169 | Maintains | Overweight | Get Alert |
| 10/04/2023 | Buy Now | 42.97% | UBS | Josh Silverstein | $206 → $210 | Maintains | Buy | Get Alert |
| 10/02/2023 | Buy Now | 13.02% | Morgan Stanley | Devin McDermott | $158 → $166 | Maintains | Overweight | Get Alert |
| 09/18/2023 | Buy Now | 21.19% | Mizuho | Nitin Kumar | $175 → $178 | Maintains | Neutral | Get Alert |
| 08/18/2023 | Buy Now | 7.57% | Morgan Stanley | Devin McDermott | $154 → $158 | Maintains | Overweight | Get Alert |
| 08/17/2023 | Buy Now | 40.25% | UBS | Josh Silverstein | $168 → $206 | Maintains | Buy | Get Alert |
| 08/16/2023 | Buy Now | 19.14% | Mizuho | Nitin Kumar | $169 → $175 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | 5.53% | Citigroup | Scott Gruber | $152 → $155 | Maintains | Neutral | Get Alert |
| 07/24/2023 | Buy Now | 13.02% | Raymond James | John Freeman | $172 → $166 | Maintains | Outperform | Get Alert |
| 07/21/2023 | Buy Now | 24.59% | Susquehanna | Biju Perincheril | $185 → $183 | Maintains | Positive | Get Alert |
| 07/18/2023 | Buy Now | 4.85% | Morgan Stanley | Devin McDermott | $158 → $154 | Maintains | Overweight | Get Alert |
| 07/11/2023 | Buy Now | 3.49% | Citigroup | Scott Gruber | $159 → $152 | Maintains | Neutral | Get Alert |
| 06/13/2023 | Buy Now | 11.66% | Piper Sandler | Ryan Todd | $168 → $164 | Maintains | Overweight | Get Alert |
| 05/19/2023 | Buy Now | 14.38% | Mizuho | Nitin Kumar | $170 → $168 | Maintains | Neutral | Get Alert |
| 05/18/2023 | Buy Now | 14.38% | Piper Sandler | Ryan Todd | $167 → $168 | Maintains | Overweight | Get Alert |
| 05/15/2023 | Buy Now | 7.57% | Morgan Stanley | Devin McDermott | $156 → $158 | Maintains | Overweight | Get Alert |
| 04/28/2023 | Buy Now | 8.25% | Citigroup | Scott Gruber | $153 → $159 | Maintains | Neutral | Get Alert |
| 04/21/2023 | Buy Now | 17.1% | Raymond James | John Freeman | $170 → $172 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | 13.7% | Piper Sandler | Ryan Todd | $166 → $167 | Maintains | Overweight | Get Alert |
| 04/19/2023 | Buy Now | 25.27% | UBS | Josh Silverstein | → $184 | Assumes | → Buy | Get Alert |
| 04/13/2023 | Buy Now | 6.21% | Morgan Stanley | Devin McDermott | $139 → $156 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | 7.57% | JP Morgan | Arun Jayaram | $156 → $158 | Maintains | Overweight | Get Alert |
| 03/27/2023 | Buy Now | -5.36% | Morgan Stanley | Devin McDermott | $130 → $139 | Maintains | Overweight | Get Alert |
| 03/24/2023 | Buy Now | -8.77% | Goldman Sachs | Neil Mehta | $170 → $134 | Maintains | Neutral | Get Alert |
| 03/10/2023 | Buy Now | 15.74% | Mizuho | Nitin Kumar | $163 → $170 | Maintains | Neutral | Get Alert |
| 03/10/2023 | Buy Now | 15.74% | Raymond James | John Freeman | $175 → $170 | Maintains | Outperform | Get Alert |
| 01/27/2023 | Buy Now | 8.93% | Citigroup | Scott Gruber | $155 → $160 | Maintains | Neutral | Get Alert |
| 01/27/2023 | Buy Now | 15.74% | Goldman Sachs | Neil Mehta | $161 → $170 | Downgrade | Buy → Neutral | Get Alert |
| 01/26/2023 | Buy Now | 36.17% | B of A Securities | Doug Leggate | $185 → $200 | Maintains | Buy | Get Alert |
| 01/26/2023 | Buy Now | 15.74% | Wells Fargo | Roger Read | $162 → $170 | Maintains | Overweight | Get Alert |
| 01/26/2023 | Buy Now | 2.12% | Credit Suisse | William Janela | $125 → $150 | Maintains | Neutral | Get Alert |
| 01/25/2023 | Buy Now | 10.97% | Mizuho | Nitin Kumar | $164 → $163 | Maintains | Neutral | Get Alert |
| 01/23/2023 | Buy Now | 8.93% | Barclays | Jeanine Wai | $155 → $160 | Maintains | Overweight | Get Alert |
| 01/23/2023 | Buy Now | 19.14% | Raymond James | John Freeman | $160 → $175 | Maintains | Outperform | Get Alert |
| 01/19/2023 | Buy Now | -11.49% | Morgan Stanley | Devin McDermott | $123 → $130 | Maintains | Overweight | Get Alert |
| 01/12/2023 | Buy Now | 23.23% | Wolfe Research | Sam Margolin | → $181 | Upgrade | Peer Perform → Outperform | Get Alert |
| 01/10/2023 | Buy Now | 10.29% | Wells Fargo | Roger Read | $159 → $162 | Maintains | Overweight | Get Alert |
| 01/10/2023 | Buy Now | 11.66% | Mizuho | Nitin Kumar | $150 → $164 | Downgrade | Buy → Neutral | Get Alert |
| 12/19/2022 | Buy Now | 6.21% | Piper Sandler | Ryan Todd | $164 → $156 | Maintains | Overweight | Get Alert |
| 12/07/2022 | Buy Now | 5.53% | Barclays | Jeanine Wai | $145 → $155 | Maintains | Overweight | Get Alert |
| 11/11/2022 | Buy Now | 11.66% | Piper Sandler | Ryan Todd | $155 → $164 | Maintains | Overweight | Get Alert |
| 10/24/2022 | Buy Now | 2.12% | Mizuho | Vincent Lovaglio | $143 → $150 | Maintains | Buy | Get Alert |
| 10/19/2022 | Buy Now | -16.26% | Morgan Stanley | Devin McDermott | $134 → $123 | Maintains | Overweight | Get Alert |
| 10/19/2022 | Buy Now | -1.28% | Barclays | Jeanine Wai | $146 → $145 | Maintains | Overweight | Get Alert |
| 10/19/2022 | Buy Now | -4.68% | Jefferies | Lloyd Byrne | → $140 | Initiates | → Hold | Get Alert |
| 10/04/2022 | Buy Now | -0.6% | JP Morgan | Arun Jayaram | $149 → $146 | Maintains | Overweight | Get Alert |
| 09/21/2022 | Buy Now | -11.49% | Citigroup | Scott Gruber | $110 → $130 | Maintains | Neutral | Get Alert |
| 08/31/2022 | Buy Now | -0.6% | Barclays | Jeanine Wai | $149 → $146 | Maintains | Overweight | Get Alert |
| 08/31/2022 | Buy Now | -4.68% | Raymond James | John Freeman | $130 → $140 | Maintains | Outperform | Get Alert |
| 08/29/2022 | Buy Now | -8.77% | Morgan Stanley | Devin McDermott | $135 → $134 | Maintains | Overweight | Get Alert |
| 07/26/2022 | Buy Now | -11.49% | Raymond James | John Freeman | $140 → $130 | Maintains | Outperform | Get Alert |
| 07/19/2022 | Buy Now | -8.09% | Morgan Stanley | Devin McDermott | $141 → $135 | Maintains | Overweight | Get Alert |
| 07/19/2022 | Buy Now | 8.93% | B of A Securities | Doug Leggate | $180 → $160 | Maintains | Buy | Get Alert |
| 07/19/2022 | Buy Now | -2.64% | Mizuho | Vincent Lovaglio | $158 → $143 | Maintains | Buy | Get Alert |
| 07/19/2022 | Buy Now | 12.34% | Piper Sandler | Ryan Todd | $161 → $165 | Maintains | Overweight | Get Alert |
| 07/15/2022 | Buy Now | 1.44% | Barclays | Jeanine Wai | $153 → $149 | Maintains | Overweight | Get Alert |
| 06/24/2022 | Buy Now | — | Citigroup | Scott Gruber | — | Downgrade | Buy → Neutral | Get Alert |
| 06/14/2022 | Buy Now | 4.17% | Barclays | Jeanine Wai | $131 → $153 | Maintains | Overweight | Get Alert |
| 06/06/2022 | Buy Now | -4% | Morgan Stanley | Devin McDermott | $137 → $141 | Maintains | Overweight | Get Alert |
| 05/31/2022 | Buy Now | 7.57% | Mizuho | Vincent Lovaglio | $139 → $158 | Maintains | Buy | Get Alert |
| 04/28/2022 | Buy Now | -8.09% | Wells Fargo | Roger Read | $133 → $135 | Maintains | Overweight | Get Alert |
| 04/25/2022 | Buy Now | -6.05% | Susquehanna | Biju Perincheril | $118 → $138 | Maintains | Positive | Get Alert |
| 04/25/2022 | Buy Now | -4.68% | Raymond James | John Freeman | $112 → $140 | Maintains | Outperform | Get Alert |
| 04/22/2022 | Buy Now | -6.73% | Morgan Stanley | Devin McDermott | $121 → $137 | Maintains | Overweight | Get Alert |
| 04/12/2022 | Buy Now | -10.81% | Barclays | Jeanine Wai | $124 → $131 | Maintains | Overweight | Get Alert |
| 03/31/2022 | Buy Now | -5.36% | Mizuho | Vincent Lovaglio | $132 → $139 | Maintains | Buy | Get Alert |
| 03/11/2022 | Buy Now | -9.45% | Wells Fargo | Roger Read | $106 → $133 | Maintains | Overweight | Get Alert |
| 01/27/2022 | Buy Now | -40.09% | Credit Suisse | William Janela | $86 → $88 | Maintains | Neutral | Get Alert |
| 01/25/2022 | Buy Now | -17.62% | Morgan Stanley | Devin McDermott | $114 → $121 | Maintains | Overweight | Get Alert |
| 01/11/2022 | Buy Now | -28.51% | Barclays | Jeanine Wai | $106 → $105 | Maintains | Overweight | Get Alert |
| 12/13/2021 | Buy Now | -22.39% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 11/30/2021 | Buy Now | -10.13% | Mizuho | Silvio Micheloto | — | Maintains | Buy | Get Alert |
| 11/19/2021 | Buy Now | -20.34% | Morgan Stanley | Devin McDermott | — | Maintains | Overweight | Get Alert |
| 10/26/2021 | Buy Now | -23.75% | Raymond James | John Freeman | — | Maintains | Outperform | Get Alert |
| 10/06/2021 | Buy Now | -21.7% | Morgan Stanley | Devin McDermott | — | Maintains | Overweight | Get Alert |
| 07/29/2021 | Buy Now | -42.81% | Credit Suisse | William Janela | — | Maintains | Neutral | Get Alert |
| 07/15/2021 | Buy Now | -21.02% | Mizuho | Vincent Lovaglio | — | Maintains | Buy | Get Alert |
FAQ
Hess (HES) 주식의 목표가는 얼마인가요?
Hess (NYSE:HES)의 최신 목표 주가는 6월 5, 2024에 Citigroup에 의해 보고되었습니다. 이 애널리스트 기관은 $160.00에 대한 가격 목표를 설정했으며, 12개월 이내에 HES이(가) rise될 것으로 예상합니다 (가능한 8.93% upside). 지난 1년간 32개의 애널리스트 기관이 평가를 보고했습니다.
Hess (HES)에 대한 가장 최근의 애널리스트 평가는 무엇인가요?
Hess (NYSE:HES)에 대한 최신 애널리스트 평가는 Citigroup에 의해 제공되었으며, Hess은(는) neutral 평가를 유지했다합니다.
Hess (HES)에 대한 마지막 업그레이드는 언제 있었나요?
Hess Corp에 대한 마지막 업그레이드는 11월 7, 2023에 발생했습니다. 이 때 Argus Research는 $171로 가격 목표를 올렸습니다. Argus Research는 이전에 Hess Corp에 대해 a hold를 가지고 있었습니다.
Hess (HES)에 대한 마지막 다운그레이드는 언제 있었나요?
Hess Corp에 대한 마지막 다운그레이드는 11월 2, 2023에 발생했습니다. 이 때 Bernstein가 Hess Corp에 대해 가격 목표를 $189에서 $166로 변경했습니다.
Hess (HES)에 대한 다음 애널리스트 평가는 언제 게시 또는 업데이트될 예정인가요?
애널리스트들은 주식 평가를 내리기 위해 철저한 연구를 진행합니다. 이 연구에는 공개된 재무 보고서를 검토하고, Hess의 경영진 및 고객과 대화하며, 실적 회의 통화를 듣는 것이 포함됩니다. 대부분의 애널리스트들은 이를 매 분기마다 수행하므로, 한 해에는 회사당 애널리스트 당 4번의 평가를 받을 수 있습니다. Hess에 대한 마지막 평가는 6월 5, 2024에 제출되었으므로, 다음 평가가 6월 5, 2025쯤에 제공될 것으로 예상됩니다.
애널리스트 평가 Hess (HES)가 올바른가요?
평가는 주관적이며 변할 수 있지만, 최신 Hess (HES) 평가는 유지했다로, 가격 목표는 $145.00에서 $160.00으로 조정되었습니다. 현재 Hess (HES)의 가격은 $146.88로, 이는 애널리스트의 예측 범위에서 within입니다.
검색 애널리스트 평가 및 가격 목표 모든 주식에 대한
사람들이 또한 지켜본다
© 2024 Benzinga | All Rights Reserved